This month in genAI: OpenAI raises $6.6B, Microsoft announces Copilot agents, Meta partners with Reuters
We highlight notable generative AI deals, partnerships, and big tech activity in October 2024.
We highlight notable generative AI deals, partnerships, and big tech activity in October 2024.
AI is helping extend retailers’ digital advertising networks’ reach across hyper-personalized content and new search platforms. We highlight opportunities for retailers, brands, ad agencies, and other industry stakeholders.
Discover the key trends our experts anticipate will shape the tech landscape in 2025.
We mined Mayo Clinic’s investments to determine how AI is shaping the next generation of healthcare.
Our panel of experts discuss the emerging technologies set to transform the way we live, work, and connect.
Quarterly AI deal count spikes to reach highest level since Q1’22 peak.
From virtual training simulators to vehicle path forecasting, we look at how generative AI is bringing vehicles closer to full automation and highlight opportunities for automakers, car insurers, and other industry stakeholders.
We examine the near- and long-term implications of Uber’s activity in autonomous vehicles across its main business lines.
Dive into the latest AI activity, and discover the emerging trends our data is signaling.
GenAI tools are moving deeper into e-commerce operations, with emerging applications in packaging design, UX optimization, supply chain management, and more. We map out tech startup activity across the ecosystem.
We highlight emerging opportunities for generative AI — from AI agents to digital twins to small language models — across the insurance value chain.
We examine how big tech and startups are developing new computing methods that could advance AI.
With early-stage activity dominating AI security, we highlight top acquisition targets in the market, CVC activity, and emerging categories to keep on your radar.
We highlight notable generative AI deals, partnerships, and big tech activity in September 2024.
We analyzed Eli Lilly’s tech-focused acquisitions, investments, and partnerships to discern the company’s strategic priorities.
From LLM developers to coding AI agents, we identify the genAI markets with the highest likelihood of exits in the next 2 years.
AI startups grab 1 in 3 VC dollars. Silicon Valley is becoming even more dominant. Positive signs from tech IPOs. We break down key changes in the venture landscape.
Which utility companies are most prepared to adopt and respond to AI? Our AI Readiness Index benchmarks the world’s largest utilities across AI innovation and execution.
Extreme weather prediction. Extending the human lifespan. The next software paradigm. We highlight 9 game-changing technologies and the key drivers and players advancing them.
Consolidation is on the horizon for legal AI agents & copilots. We mined CB Insights buyer interviews, Mosaic scores, exit probabilities, and funding data to forecast what’s next for the market.
We are running out of high-quality data to train LLMs, driving up demand for synthetic datasets. We dig into how adoption is picking up and the rising players in the space.
From neural processing units (NPUs) to quantum computing, we break down the categories of tech companies powering the AI explosion.
Healthcare incumbents, big tech, and startups alike are using AI to address key pain points in clinical workflows. We break down the fast-growing market for ambient AI solutions in healthcare.
This report uses the CB Insights TECH Framework to rank clinical trials markets based on current commercial readiness and momentum.
We map the startups in the AI agents space based on their Commercial Maturity scores.
From rapid, on-site diagnostics to novel stem cell therapies, animal health is seeing a wave of innovations to prevent, diagnose, and treat disease.